2017
DOI: 10.1007/s00120-017-0428-y
|View full text |Cite
|
Sign up to set email alerts
|

Neue (und alte) Aspekte der retroperitonealen Fibrose

Abstract: Retroperitoneal fibrosis (RPF) is an uncommon chronic inflammatory disease of the rear abdomen and it is commonly associated with the complication of uni- or bilateral hydronephrosis. Despite the rarity of this disease, multiple publications concerning etiology, diagnosis, therapy monitoring and both medical and surgical therapy have been published in recent years. Recent research has focused on asbestos exposure as a possible risk factor, the meaning of IgG4-associated RPF, measuring disease activity using di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
1
0
4

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 55 publications
0
1
0
4
Order By: Relevance
“…Malignant RF is refractory to pharmacologic treatment with immunosuppressants. Therefore, the focus should be on the diagnosis and treatment of the underlying neoplasm (17). Because recognition of a neoplastic cause alters the therapeutic approach, management algorithms for the diagnosis of secondary RF have been proposed, emphasizing the need for PET to detect active fibrosis or cancer and to guide biopsy (18,19).…”
Section: Discussionmentioning
confidence: 99%
“…Malignant RF is refractory to pharmacologic treatment with immunosuppressants. Therefore, the focus should be on the diagnosis and treatment of the underlying neoplasm (17). Because recognition of a neoplastic cause alters the therapeutic approach, management algorithms for the diagnosis of secondary RF have been proposed, emphasizing the need for PET to detect active fibrosis or cancer and to guide biopsy (18,19).…”
Section: Discussionmentioning
confidence: 99%
“…Die radiologische Bildgebung besitzt eine zentrale Rolle und stellt den Goldstandard in der Diagnostik und Verlaufskontrolle der RPF dar, da sie entscheidet, ob z. B. Doppel-J-Schienen entfernt werden können oder eine Medikation pausiert wird, während der Stellenwert vieler Laborparameter als Therapiemonitoring weiterhin unklar bleibt [11,22].…”
Section: Bildmorphologische Merkmaleunclassified
“…Dennoch kommt es bei einem Teil der Patienten (ca. 18 %) im Langzeitverlauf zu einer Atrophie des vormals betroffenen Organs [11].…”
Section: Therapieunclassified
See 2 more Smart Citations